[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349167-105":59,"doc-detail-349167-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","adam9-in-tumor-biology-molecular-functions-clinical-implications-and-therapeutic-targeting","ADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting","","A disintegrin and metalloproteinase 9 (ADAM9), an ADAM-family membrane glycoprotein, is expressed across multiple organs and contributes to many physiological processes. Strong evidence links ADAM9 to cancer progression via extracellular matrix (ECM) remodeling, protein shedding, and modulation of the tumor microenvironment. This review summarizes ADAM9’s clinical relevance and mechanistic roles, including pan-cancer upregulation and association with poor prognosis, correlation with immunosuppressive TME, and activation of cancer-promoting pathways such as cell-cycle progression, EMT, and metabolism, while evaluating ADAM9-targeted therapies as biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/adam9-in-tumor-biology-molecular-functions-clinical-implications-and-therapeutic-targeting/349167/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/adam9-in-tumor-biology-molecular-functions-clinical-implications-and-therapeutic-targeting/349167.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How is ADAM9 linked to cancer progression?","Question",{"text":112,"@type":113},"ADAM9 contributes to cancer progression through extracellular matrix (ECM) remodeling, protein shedding, and modulation of the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the pan-cancer analysis suggest about ADAM9 expression and prognosis?",{"text":117,"@type":113},"ADAM9 is frequently upregulated and consistently associated with poor prognosis across tumor types.",{"name":119,"@type":110,"acceptedAnswer":120},"Which tumor-promoting pathways are associated with increased ADAM9 expression?",{"text":121,"@type":113},"Increased ADAM9 expression correlates with activation of cell-cycle progression, epithelial–mesenchymal transition (EMT), and metabolism pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349167,1791114477,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Ho et al. Cellular & Molecular Biology Letters (2026) 31:74 [https://doi.org/10.1186/s11658-026-00910-2](https://doi.org/10.1186/s11658-026-00910-2)  \nCellular & Molecular Biology Letters  \nREVIEW Open Access  \nADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting  \nKuo-Hao Ho 1, Chao-Jung Wu2, Yi-Chieh Yang3* and Ming-Hsien Chien2,4,5,6,7*  \n*Correspondence:  \nYi-Chieh Yang [ycyang@tmu.edu.tw](ycyang@tmu.edu.tw)[ ](ycyang@tmu.edu.tw)Ming-Hsien Chien [mhchien1976@gmail.com](mhchien1976@gmail.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nA disintegrin and metalloproteinase 9 (ADAM9), a member of the ADAM family, is expressed across multiple organs and is crucial to multiple physiological processes. Increasing evidence implicates ADAM9 in cancer progression through extracellular matrix (ECM) remodeling, protein shedding, and tumor microenvironment modulation. This study comprehensively reviews the literature on the clinical significance of ADAM9 and the mechanistic roles of ADAM9 in cancer. The results of our pan-cancer analysis demonstrated that ADAM9 is frequently upregulated and consistently associated with poor prognosis across tumor types. The results of in silico analyses also revealed that increased ADAM9 expression is correlated with an immunosuppressive tumor microenvironment and the activation of cancerpromoting pathways, such as cell cycle progression, epithelial–mesenchymal transition (EMT), and metabolism. This study also reviewed therapeutic strategies targeting ADAM9 and evaluated their potential in cancer treatment. This review provides insights into ADAM9 as both a biomarker of malignancy and a promising therapeutic target.  \nKeywords A disintegrin and metalloproteinase 9 (ADAM9), Extracellular matrix (ECM) remodeling, Protein shedding, Tumor microenvironment (TME), Cancer progression  \nBackground  \nMetalloprotease-disintegrin proteins, also termed metalloprotease/disintegrin/cysteine-rich or ADAM (a disintegrin and metalloprotease) proteins, are a family of membrane-anchored glycoproteins involved in multiple physiological processes, such as neurogenesis, the binding and fusion of sperm/egg cells or myoblasts, and the regulation of signaling pathways, such as the Notch-, Wnt-, and NFκB-pathways [1–3]. More than 20 ADAM family members have been identified in human cells, and approximately half exhibit functional metalloprotease activity and participate in proteolytic processes. ADAM family members are critical regulators of both physiological and pathological cellular processes. For example, ADAMs are crucial to the proteolytic processing of pro-inflammatory cytokines [4] and the ectodomain shedding of membrane-bound precursors such as pro-heparin-binding epidermal-growth-factor (pro-HB-EGF), a ligand of the epidermal growth factor receptor (EGFR) [5]. Additionally, ADAMs are involved  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/","cbCain79rFeDiBTR","https://ap.wps.com/l/cbCain79rFeDiBTR","pdf",2692036,"English","# Background\n## Structure and functional domains of ADAM9","[{\"question\":\"How is ADAM9 linked to cancer progression?\",\"answer\":\"ADAM9 contributes to cancer progression through extracellular matrix (ECM) remodeling, protein shedding, and modulation of the tumor microenvironment.\"},{\"question\":\"What does the pan-cancer analysis suggest about ADAM9 expression and prognosis?\",\"answer\":\"ADAM9 is frequently upregulated and consistently associated with poor prognosis across tumor types.\"},{\"question\":\"Which tumor-promoting pathways are associated with increased ADAM9 expression?\",\"answer\":\"Increased ADAM9 expression correlates with activation of cell-cycle progression, epithelial–mesenchymal transition (EMT), and metabolism pathways.\"}]","ADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting | PDF",1790082031,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af42bd8a429dffde75c5d7844103013b.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a7cbe423b3f26f0f14da6823f2468fe.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/385d39d28554bef22b09a3c9c63eb144.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35ee7cc31a7cea71c25fb4b13c1aa629.webp",980,1306]